None listed
Conditions
Interventions
Intervention1: MTP by Misoprostol and Mifepristone: Group A (n=30): In this group, the patients will be given oral 10 mg of letrozole for three
consecutive days followed by recommended dose of Misopr
Sponsors
King George Medical University Department of Obstetrics and Gynaecology
Eligibility
Inclusion criteria
Inclusion criteria: Gestational age 5 weeks to 24 weeks as confirmed by ultrasound scanning on day 1 of the study
Exclusion criteria
Exclusion criteria: Women not giving consent or having contraindication(s) to misoprostol (glaucoma, mitral stenosis, poorly controlled seizure disorders or known allergy to Prostaglandins) or having history or evidence of adrenal pathology, or being steroid-dependent, or having cancer, or having porphyria, or having diastolic pressure over 95 mmHg, or having bronchial asthma, or having arterial hypertension, or having history or evidence of thromboembolism, or having severe or recurrent liver disease, or having regular use of prescription drugs before admission to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete abortion rates in first and second trimester.Timepoint: at the day of intervention and 15 days later of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Induction-abortion interval in first and second trimester (Continuous data) - Drug related side effects (Categorical outcome)Timepoint: at the day of intervention and 15 days later of intervention | — |
Countries
India
Contacts
Public ContactDr Arusha Tiwari
King Georges Medical University
Outcome results
None listed